SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-249352
Filing Date
2017-08-07
Accepted
2017-08-07 08:30:57
Documents
4
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d423672dsc13d.htm SC 13D 92087
2 EX-99.1 d423672dex991.htm EX-99.1 5129
3 EX-99.2 d423672dex992.htm EX-99.2 7696
4 GRAPHIC g423672g94r26.jpg GRAPHIC 3996
  Complete submission text file 0001193125-17-249352.txt   112448
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81801 | Film No.: 171010168
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

IRS No.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D